FDA clears sacroiliac joint fixation system from Aurora Spine

Aurora Spine (OTCQB:ASAPF) announced that it received FDA 510(k) clearance for its SiLO TFX MIS sacroiliac joint fixation system.

In a news release, the company described SiLo TFX MIS as a patented and minimally invasive system.

Carlsbad, California-based Aurora Spine said it plans to disclose additional details regarding the system tomorrow, Oct. 6, 2022. This story may be updated.

 

Read more
  • 0